Estabrook Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.33K | Buy |
+116
| New | +$8.94K | ﹤0.01% | 285 |
|
|
2025
Q1 | – | Sell |
-18,771
| Closed | -$843K | – | 334 |
|
|
2024
Q4 | $843K | Sell |
18,771
-20,800
| -53% | -$1.17M | 0.13% | 83 |
|
|
2024
Q3 | $2.49M | Sell |
39,571
-2,800
| -7% | -$163K | 0.37% | 59 |
|
|
2024
Q2 | $2.5M | Sell |
42,371
-1,619
| -4% | -$101K | 0.39% | 58 |
|
|
2024
Q1 | $3.51M | Sell |
43,990
-75
| -0.2% | -$5.73K | 0.54% | 46 |
|
|
2023
Q4 | $3.48M | Sell |
44,065
-1,850
| -4% | -$132K | 0.57% | 46 |
|
|
2023
Q3 | $3.21M | Sell |
45,915
-510
| -1% | -$36.1K | 0.56% | 45 |
|
|
2023
Q2 | $3.21M | Sell |
46,425
-700
| -1% | -$49.8K | 0.53% | 50 |
|
|
2023
Q1 | $3.5M | Hold |
47,125
| – | – | 0.61% | 47 |
|
|
2022
Q4 | $4.39M | Buy |
47,125
+3
| +0% | +$289 | 0.76% | 38 |
|
|
2022
Q3 | $4.49M | Sell |
47,122
-80
| -0.2% | -$7.92K | 0.84% | 36 |
|
|
2022
Q2 | $4.37M | Sell |
47,202
-747
| -2% | -$72.9K | 0.75% | 38 |
|
|
2022
Q1 | $4.85M | Buy |
47,949
+7
| +0% | +$735 | 0.71% | 40 |
|
|
2021
Q4 | $4.95M | Buy |
47,942
+2,608
| +6% | +$241K | 0.7% | 39 |
|
|
2021
Q3 | $3.85M | Sell |
45,334
-809
| -2% | -$67.8K | 0.61% | 50 |
|
|
2021
Q2 | $3.85M | Sell |
46,143
-2,992
| -6% | -$245K | 0.59% | 51 |
|
|
2021
Q1 | $3.7M | Buy |
49,135
+427
| +0.9% | +$31.1K | 0.57% | 52 |
|
|
2020
Q4 | $3.33M | Sell |
48,708
-396
| -0.8% | -$25.8K | 0.55% | 52 |
|
|
2020
Q3 | $2.87M | Buy |
49,104
+45,454
| +1,245% | +$2.83M | 0.53% | 52 |
|
|
2020
Q2 | $237K | Buy |
3,650
+175
| +5% | +$11K | 0.05% | 121 |
|
|
2020
Q1 | $206K | Buy |
3,475
+175
| +5% | +$11.7K | 0.04% | 118 |
|
|
2019
Q4 | $245K | Buy |
3,300
+2,879
| +684% | +$202K | 0.04% | 132 |
|
|
2019
Q3 | $26.6K | Buy |
421
+121
| +40% | +$7.17K | ﹤0.01% | 243 |
|
|
2019
Q2 | $16.3K | Hold |
300
| – | – | ﹤0.01% | 268 |
|
|
2019
Q1 | $16.2K | Buy |
300
+288
| +2,400% | +$17.8K | ﹤0.01% | 275 |
|
|
2018
Q4 | $786 | Hold |
12
| – | – | ﹤0.01% | 320 |
|
|
2018
Q3 | $945 | Sell |
12
-250
| -95% | -$17.9K | ﹤0.01% | 342 |
|
|
2018
Q2 | $16.9K | Sell |
262
-180
| -41% | -$11.9K | ﹤0.01% | 297 |
|
|
2018
Q1 | $27.5K | Sell |
442
-775
| -64% | -$55.6K | ﹤0.01% | 265 |
|
|
2017
Q4 | $88.2K | Sell |
1,217
-3,990
| -77% | -$290K | 0.01% | 189 |
|
|
2017
Q3 | $423K | Sell |
5,207
-1,730
| -25% | -$137K | 0.07% | 108 |
|
|
2017
Q2 | $558K | Sell |
6,937
-820
| -11% | -$64.7K | 0.09% | 99 |
|
|
2017
Q1 | $609K | Sell |
7,757
-1,740
| -18% | -$139K | 0.1% | 93 |
|
|
2016
Q4 | $749K | Sell |
9,497
-47,932
| -83% | -$3.88M | 0.12% | 86 |
|
|
2016
Q3 | $5.11M | Buy |
57,429
+7,050
| +14% | +$665K | 0.75% | 42 |
|
|
2016
Q2 | $4.82M | Sell |
50,379
-3,233
| -6% | -$322K | 0.72% | 41 |
|
|
2016
Q1 | $5.56M | Buy |
53,612
+2,570
| +5% | +$250K | 0.82% | 42 |
|
|
2015
Q4 | $4.99M | Buy |
51,042
+6,123
| +14% | +$600K | 0.72% | 42 |
|
|
2015
Q3 | $4.33M | Buy |
44,919
+27,855
| +163% | +$2.93M | 0.63% | 45 |
|
|
2015
Q2 | $1.79M | Buy |
17,064
+8,354
| +96% | +$854K | 0.22% | 67 |
|
|
2015
Q1 | $899K | Buy |
+8,710
| New | +$881K | 0.11% | 92 |
|
Other funds holding CVS
VCM
VPM
Estabrook Capital Management's CVS Position: Q1 2026 in Review
Estabrook Capital Management opened a new position in CVS Health (CVS) in Q1 2026: 116 shares worth $8.33K. The stake represents ﹤0.01% of the portfolio and ranks #285 among its holdings. This is a return to the name: Estabrook Capital Management previously reported a position in CVS as recently as Q4 2024.
Estabrook Capital Management first reported a position in CVS in Q1 2015 and has held it in 41 quarters since. The position peaked at $5.56M in Q1 2016. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Estabrook Capital Management held 116 shares of CVS Health worth $8.33K as of Q1 2026.
- CVS Health was a new Estabrook Capital Management position in Q1 2026.
- CVS Health made up ﹤0.01% of Estabrook Capital Management's portfolio in Q1 2026, its #285 holding.
- Estabrook Capital Management first reported a position in CVS Health in Q1 2015 and has held it in 41 quarters since.
- Estabrook Capital Management's CVS Health position peaked at $5.56M in Q1 2016.
- 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.